Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0800
    +0.0007 (+0.06%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2637
    +0.0015 (+0.12%)
     
  • USD/JPY

    151.1970
    -0.1750 (-0.12%)
     
  • Bitcoin USD

    70,390.48
    -379.49 (-0.54%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

Today's Research Reports on Trending Tickers: American Superconductor and Merrimack Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / September 7, 2017 / After posting the worst daily drop in weeks on rising geopolitical tensions between North Korea and the from their worst daily drop in weeks, U.S. markets rebounded Wednesday. The Dow Jones Industrial Average gained 0.25 percent to close at 21,807.64, while the S&P 500 Index increased 0.31 percent to close at 2,465.54. The NASDAQ Composite Index rose 0.28 percent to close at 6,393.31. Major indexes rallied Wednesday as President Donald Trump and congressional leaders agreed to extend the debt ceiling and fund the government for an additional three months.

"While the [market] outlook is generally positive, there are a lot of risk factors out there," said Richard Benson, co-head of portfolio investments at Millennium Global Investments. "I'm positive but worried."

RDI Initiates Coverage on:

American Superconductor Corporation
https://rdinvesting.com/news/?ticker=AMSC

Merrimack Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=MACK

American Superconductor Corporation's stock moved 1.30% higher Wednesday, to close the day at $3.90. The stock recorded a trading volume of 91,520 shares, which was below its three months average volume of 184,556 shares. In the last year American Superconductor Corporation's shares have traded in a range of 2.89 - 8.55. The share price has gained 34.95% from its 52 week low. The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $3.56 is below its 200-day moving average of $4.92. Shares of American Superconductor have fallen approximately 47.08 percent year-to-date.

Access RDI's American Superconductor Corporation Research Report at:
https://rdinvesting.com/news/?ticker=AMSC

On Wednesday, shares of Merrimack Pharmaceuticals Inc. recorded a trading volume of 441,320 shares, which was below the three months average volume of 2,101,550 shares. The stock ended the day 5.76% lower at 11.78. The share price has gained 942.48% from its 52 week low with a 52 week trading range of 1.13 - 12.66.The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $1.29 is below its 200-day moving average of $2.28. Shares of the company are trading at a Price to Earnings ratio of 3.67. Shares of Merrimack Pharmaceuticals have gained approximately 188.73 percent year-to-date.

Access RDI's Merrimack Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=MACK

Our Actionable Research on American Superconductor Corporation (NASDAQ:AMSC) and Merrimack Pharmaceuticals Inc. (NASDAQ:MACK) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

Advertisement